Olmesartan medoxomil and Cevimeline drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Olmesartan medoxomil (olmesartan medoxomil) and Cevimeline (cevimeline hydrochloride). Common drug interactions include anaemia among females and blood creatine phosphokinase increased among males.
The phase IV clinical study analyzes what interactions people have when they take Olmesartan medoxomil and Cevimeline. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Olmesartan medoxomil?
Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.
What is Cevimeline?
Cevimeline has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,480 Cevimeline users. Check the latest studies of Cevimeline.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11 people who take Olmesartan medoxomil and Cevimeline together, and have interactions are studied.

What are the common drug interactions of Olmesartan Medoxomil and Cevimeline, by gender? *:
female:
- Anaemia (lack of blood)
- Myalgia (muscle pain)
- Anxiety
- Fungal skin infection
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Glossodynia (a burning or painful sensation in the tongue)
- Haematochezia (passage of stools containing blood)
- Herpes zoster
- Hyperlipidaemia (presence of excess lipids in the blood)
- Localised infection (infection at the single location)
male:
- Blood creatine phosphokinase increased
- Blood potassium decreased
What are the common drug interactions of Olmesartan Medoxomil and Cevimeline, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anaemia (lack of blood)
- Fungal skin infection
- Herpes zoster
- Hyperlipidaemia (presence of excess lipids in the blood)
- Ovarian cyst (fluid filled sac of the ovary)
- Upper respiratory tract inflammation
40-49:
n/a
50-59:
- Blood creatine phosphokinase increased
- Blood potassium decreased
- Asthma
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Headache (pain in head)
- Memory impairment
- Neuralgia (pain in one or more nerves)
- Oxygen consumption increased
- Pain
- Pneumonia
60+:
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Glossodynia (a burning or painful sensation in the tongue)
- Haematochezia (passage of stools containing blood)
- Localised infection (infection at the single location)
- Oral pain
- Pain of skin
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Sinus headache (headache caused by sinus infections)
- Stomatitis (inflammation of mucous membrane of mouth)
- Weight decreased
What are the existing conditions these people have? *
- Hiv Infection: 5 people, 45.45%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 36.36%
- Thyroid Cancer: 1 person, 9.09%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Olmesartan medoxomil and Cevimeline?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Olmesartan medoxomil (15,240 reports)
- Cevimeline (1,480 reports)
Browse all drug interactions of Olmesartan medoxomil and Cevimeline:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olmesartan medoxomil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cevimeline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olmesartan medoxomil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cevimeline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olmesartan medoxomil and cevimeline hydrochloride (the active ingredients of Olmesartan medoxomil and Cevimeline, respectively), and Olmesartan medoxomil and Cevimeline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Rhopressa cause Drug Hypersensitivity? - a second ago
- Could Nifedipine cause Injection Site Erythema? - a second ago
- Could Detrol cause Difficulty In Walking? - 6 seconds ago
- Could Aimovig cause Skin Disorder? - 6 seconds ago
- Could Pyrimethamine cause Lung Disorder? - 7 seconds ago
- Could Detrol cause Pollakiuria? - 9 seconds ago
- Could Fungizone cause Herpes Zoster? - 11 seconds ago
- Could Hizentra cause Injection Site Necrosis? - 12 seconds ago
- Could Niaspan cause Glaucoma? - 20 seconds ago
- Could Niaspan cause Muscle Cramps Aggravated? - 24 seconds ago